191 related articles for article (PubMed ID: 11996670)
1. The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.
Yu T; Robb VA; Singh V; Gutmann DH; Newsham IF
Biochem J; 2002 Aug; 365(Pt 3):783-9. PubMed ID: 11996670
[TBL] [Abstract][Full Text] [Related]
2. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
3. DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.
Singh V; Miranda TB; Jiang W; Frankel A; Roemer ME; Robb VA; Gutmann DH; Herschman HR; Clarke S; Newsham IF
Oncogene; 2004 Oct; 23(47):7761-71. PubMed ID: 15334060
[TBL] [Abstract][Full Text] [Related]
4. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
Gutmann DH; Donahoe J; Perry A; Lemke N; Gorse K; Kittiniyom K; Rempel SA; Gutierrez JA; Newsham IF
Hum Mol Genet; 2000 Jun; 9(10):1495-500. PubMed ID: 10888600
[TBL] [Abstract][Full Text] [Related]
5. Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression.
Robb VA; Li W; Gutmann DH
Oncogene; 2004 Apr; 23(20):3589-96. PubMed ID: 15116094
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the DAL-1/4.1B tumour-suppressor gene locus in meningiomas.
Martinez-Glez V; Bello MJ; Franco-Hernandez C; De Campos JM; Isla A; Vaquero J; Rey JA
Int J Mol Med; 2005 Oct; 16(4):771-4. PubMed ID: 16142420
[TBL] [Abstract][Full Text] [Related]
7. ERM proteins and merlin: integrators at the cell cortex.
Bretscher A; Edwards K; Fehon RG
Nat Rev Mol Cell Biol; 2002 Aug; 3(8):586-99. PubMed ID: 12154370
[TBL] [Abstract][Full Text] [Related]
8. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
[TBL] [Abstract][Full Text] [Related]
9. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.
Bono P; Cordero E; Johnson K; Borowsky M; Ramesh V; Jacks T; Hynes RO
Exp Cell Res; 2005 Aug; 308(1):177-87. PubMed ID: 15913605
[TBL] [Abstract][Full Text] [Related]
10. Radixin: cytoskeletal adopter and signaling protein.
Hoeflich KP; Ikura M
Int J Biochem Cell Biol; 2004 Nov; 36(11):2131-6. PubMed ID: 15313460
[TBL] [Abstract][Full Text] [Related]
11. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
[TBL] [Abstract][Full Text] [Related]
12. Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer.
Yi C; McCarty JH; Troutman SA; Eckman MS; Bronson RT; Kissil JL
Mol Cell Biol; 2005 Nov; 25(22):10052-9. PubMed ID: 16260618
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the ERM proteins in lung adenocarcinoma.
Tokunou M; Niki T; Saitoh Y; Imamura H; Sakamoto M; Hirohashi S
Lab Invest; 2000 Nov; 80(11):1643-50. PubMed ID: 11092524
[TBL] [Abstract][Full Text] [Related]
14. Universal absence of merlin, but not other ERM family members, in schwannomas.
Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
[TBL] [Abstract][Full Text] [Related]
15. The cytoplasmic tail of L-selectin interacts with members of the Ezrin-Radixin-Moesin (ERM) family of proteins: cell activation-dependent binding of Moesin but not Ezrin.
Ivetic A; Deka J; Ridley A; Ager A
J Biol Chem; 2002 Jan; 277(3):2321-9. PubMed ID: 11706008
[TBL] [Abstract][Full Text] [Related]
16. Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.
Nguyen R; Reczek D; Bretscher A
J Biol Chem; 2001 Mar; 276(10):7621-9. PubMed ID: 11106646
[TBL] [Abstract][Full Text] [Related]
17. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho.
Lamb RF; Roy C; Diefenbach TJ; Vinters HV; Johnson MW; Jay DG; Hall A
Nat Cell Biol; 2000 May; 2(5):281-7. PubMed ID: 10806479
[TBL] [Abstract][Full Text] [Related]
18. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
[TBL] [Abstract][Full Text] [Related]
19. Two Sides of the Coin: Ezrin/Radixin/Moesin and Merlin Control Membrane Structure and Contact Inhibition.
Michie KA; Bermeister A; Robertson NO; Goodchild SC; Curmi PMG
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018575
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor DAL-1/4.1B modulates protein arginine N-methyltransferase 5 activity in a substrate-specific manner.
Jiang W; Roemer ME; Newsham IF
Biochem Biophys Res Commun; 2005 Apr; 329(2):522-30. PubMed ID: 15737618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
